Thromb Haemost 1998; 80(06): 894-898
DOI: 10.1055/s-0037-1615384
Letters to the Editor
Schattauer GmbH

Tissue Factor Expression and Metastatic Potential of Colorectal Cancer

Chika Shigemori
1   Department of Surgery II
,
Hideo Wada
2   Department of Internal Medicine II, Mie University Medical School, Tsu, Japan
,
Kouichi Matsumoto
1   Department of Surgery II
,
Hiroshi Shiku
2   Department of Internal Medicine II, Mie University Medical School, Tsu, Japan
,
Shin Nakamura
3   Department of Cellular and Molecular Biology, Primate Research Institute, Kyoto University, Inuyama, Japan
,
Hiroshi Suzuki
1   Department of Surgery II
› Author Affiliations
Further Information

Publication History

Received 13 May 1998

Accepted after revision 17 August 1998

Publication Date:
07 December 2017 (online)

Preview

Summary

Several studies have previously demonstrated tissue factor (TF) expression in solid tumors. In our study, we evaluated by immunohistochemical staining TF expression in 79 cases of colorectal cancer and 17 cases of metastatic cancer of the liver from colorectal cancer, and investigated the relationship between the clinicopathological features and TF expression.

TF was detected in the tumor of 57% of colorectal cancer patients, and its expression was significantly increased (p = 0.01) in metastatic tumors (88%). TF expression was more commonly observed in meta-static tumors than in any Dukes’ stage of primary cancer. In primary cancer, the detection of TF was more frequent in cases with lymph node metastasis (Dukes’ C, 63%) or with hematogenous metastasis (Dukes’ D, 82%) than in tumors without lymph node or hematogenous metastasis (Dukes’ A and B, 46%, p = 0.03).

These results suggest that the expression of TF is related with the metastatic potential of colorectal cancer.